NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 255 filers reported holding NOVAVAX INC in Q3 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $86,334 | -25.3% | 12,458 | +10.9% | 0.00% | -50.0% |
| Q4 2022 | $115,506 | -75.6% | 11,236 | +21.9% | 0.00% | -80.0% |
| Q2 2022 | $474,000 | -25.9% | 9,218 | +6.0% | 0.01% | -9.1% |
| Q1 2022 | $640,000 | -48.0% | 8,695 | +1.1% | 0.01% | -42.1% |
| Q4 2021 | $1,230,000 | -29.1% | 8,600 | +2.8% | 0.02% | -42.4% |
| Q3 2021 | $1,734,000 | -6.0% | 8,362 | -3.7% | 0.03% | -2.9% |
| Q2 2021 | $1,844,000 | +723.2% | 8,687 | +223.4% | 0.03% | +466.7% |
| Q2 2020 | $224,000 | – | 2,686 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 3,002,087 | $544,308,000 | 8.21% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 323,517 | $58,657,000 | 7.86% |
| Samsara BioCapital, LLC | 198,600 | $36,008,000 | 6.64% |
| Foresite Capital Management I, LLC | 66,810 | $12,113,000 | 6.11% |
| Foresite Capital Management II, LLC | 67,373 | $12,215,000 | 2.81% |
| SECTORAL ASSET MANAGEMENT INC | 191,200 | $34,666,000 | 2.63% |
| Rock Springs Capital Management LP | 461,000 | $83,584,000 | 1.82% |
| TSP Capital Management Group, LLC | 23,525 | $4,265,000 | 1.50% |
| Ikarian Capital, LLC | 195,700 | $35,483,000 | 1.19% |
| SevenOneSeven Capital Management | 1,744 | $316,000 | 1.16% |